- Abstract:
-
Safety and clinical feasibility of injecting a novel liquid fiducial marker for use in image guided radiotherapy in 15 patients with non-small cell lung cancer are reported. No major safety or toxicity issues were encountered. Markers present at start of radiotherapy remained visible in cone beam computed tomography and fluoroscopy images throughout the treatment course and on computed tomography images during follow-up (0-38 months). Marker volume reduction was seen until 9 months after trea...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Publisher:
- Elsevier Publisher's website
- Journal:
- Clinical and Translational Radiation Oncology Journal website
- Volume:
- 13
- Pages:
- 24-28
- Publication date:
- 2018-08-02
- Acceptance date:
- 2018-07-31
- DOI:
- EISSN:
-
2405-6308
- Pubs id:
-
pubs:923375
- URN:
-
uri:23e19f3d-9488-403b-b880-200042e4db83
- UUID:
-
uuid:23e19f3d-9488-403b-b880-200042e4db83
- Local pid:
- pubs:923375
- Language:
- English
- Keywords:
- Copyright holder:
- de Blanck et al
- Copyright date:
- 2018
- Notes:
- © 2018 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Journal article
Long term safety and visibility of a novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancer
Actions
Authors
Funding
Danish Council for Strategic Research
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record